Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from NMPA

Elon Musk's X Faces $250M Copyright Lawsuit Over Alleged Music Piracy Facilitation

A federal judge allows part of a $250 million copyright lawsuit against Elon Musk's X to proceed, alleging music piracy facilitation.

International Business Times

Execs see music streaming services as ‘undervalued’ – prepare for more price hikes

Music streaming services have finally started to follow video streaming services with price increases. Expect more to come.

TechRadar

Karnataka to release its maritime policy to develop port sector shortly

Karnataka Maritime Policy will be released soon said Gaurav Gupta, Additional Chief Secretary, Infrastructure Development, Ports and Inland Water Transport during the inaugural session of the first edition of Karnataka Ports Conference – 2023 in Mangaluru

The Hindu

From analysis to the latest developments in health,
read the most diverse news in one place.

Sony, Universal, and 15 other music publishers are suing Twitter for stealing their content, and using Elon Musk’s own words against him. He’s called copyright a ‘plague on humanity’

Twitter could owe the publishers over $250 million because more than 1,000 songs are on the platform in violation of the law.

Fortune

NMPA conducts workshop on maritime adversities

The New Mangalore Port Authority on June 2, Friday, conducted a workshop on Maritime Adversities aimed at enhancing awareness and preparedness among all stakeholders and port users on the challenges faced in the maritime industry and the strategies to mitigate potential adversities.

The Hindu

Warning to anyone with a pension as major law set to change

“Don’t be locked out of your money because you haven’t made the necessary moves when it comes to your pension”

Wales Online

Investors are in a race to acquire music rights. Here’s why they should be looking to Broadway instead in 2023

Both music and theatrical copyrights can run with little to no overhead and generate significant licensing income.

Fortune

Read news from The Economist, FT, and more,
with one subscription

The Daily Biotech Pulse: BioXcel's Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy

Here's a roundup of top developments in the biotech space over the last 24 hours.

Benzinga

Dynavax Adjuvanted Clover Bio's COVID-19 Vaccine Booster Shows Durable Protection Against Omicron

Clover Biopharmaceuticals Ltd's follow-up analysis for efficacy in the SPECTRA Phase 2/3 trial of SCB-2019 COVID-19 vaccine provided high and durable protection in individuals five months after the second dose. The follow-up analysis involved 26,400 individuals. Against any variant, efficacy was maintained at 100% against severe COVID-19 and 95% against COVID-19 associated…

Benzinga

China Approves Five COVID-19 Antigen Kits for Self-testing

China has granted approval to five COVID-19 antigen kits made by local companies to be used for self-testing, state broadcaster CCTV said on Saturday, as it tweaks its testing regime that has been pressured by Omicron. China's National Medical Products Administration (NMPA) published a notice on Friday saying Beijing Huaketai…

Asharq Al-Awsat

Sellas Life Sciences Shares Jump As China Approves Galinpepimut IND For Blood Cancer

China's National Medical Products Administration (NMPA)

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.